[{"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-001", "question": "A 35-year-old man develops DRESS syndrome 3 weeks after starting phenytoin. He has fever, eosinophilia, atypical lymphocytosis, and transaminitis (AST 450 U/L). HHV-6 PCR becomes positive at day 16 of illness. What is the clinical significance of this virologic finding?", "options": ["Confirms phenytoin as the causative drug", "Indicates need for ganciclovir antiviral therapy", "Predicts higher risk of disease flare and organ damage", "Represents asymptomatic viral reactivation without prognostic value", "Suggests alternative diagnosis of acute HHV-6 infection"], "answer": "C", "answer_index": 2, "explanation": "HHV-6 reactivation at weeks 2-3 in DRESS is pathogenically linked to disease severity, predicting higher risk of relapse, end-organ damage, and prolonged course. It indicates need for more aggressive immunosuppression, not antiviral therapy, as the virus is a marker of immune dysregulation.", "generator_model": "kimi-k2-thinking", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "abms_specialty": "Dermatology", "abms_source": "topics_mapped", "source_label_raw": "Dermatology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed126", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed126-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed126.jsonl", "pred": "C", "model_outputs": "Let me analyze this case of DRESS syndrome with HHV-6 reactivation.\n\nDRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome is a severe drug hypersensitivity reaction characterized by:\n- Fever\n- Skin eruption\n- Eosinophilia\n- Atypical lymphocytosis\n- Internal organ involvement (liver, kidney, etc.)\n- Typically occurs 2-8 weeks after drug initiation\n\nHHV-6 reactivation is a well-documented phenomenon in DRESS syndrome, occurring in approximately 40-60% of cases. Let me evaluate each option:\n\nA. Confirms phenytoin as the causative drug - HHV-6 reactivation doesn't confirm the causative drug; it's a consequence of the immune dysregulation in DRESS, not a marker of specific drug causation.\n\nB. Indicates need for ganciclovir antiviral therapy - Antiviral therapy is not routinely recommended for HHV-6 reactivation in DRESS. Treatment focuses on drug withdrawal and corticosteroids.\n\nC. Predicts higher risk of disease flare and organ damage - Studies have shown that HHV-6 reactivation in DRESS is associated with more severe disease, prolonged course, higher risk of relapse/flares, and greater organ involvement. This is clinically significant.\n\nD. Represents asymptomatic viral reactivation without prognostic value - This is incorrect; HHV-6 reactivation does have prognostic significance in DRESS.\n\nE. Suggests alternative diagnosis of acute HHV-6 infection - Primary HHV-6 infection typically occurs in childhood. In adults with DRESS, positive HHV-6 PCR represents reactivation, not primary infection, and doesn't suggest an alternative diagnosis.\n\nThe clinical significance of HHV-6 reactivation in DRESS is that it correlates with disease severity, prolonged course, and increased risk of flares and organ damage. Multiple studies have demonstrated this association.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-002", "question": "A 58-year-old kidney transplant recipient (deceased donor, 8 months post-transplant) presents with rising creatinine from 1.2 to 2.1 mg/dL. Plasma BK virus PCR is 18,000 copies/mL. Allograft biopsy shows Banff class B BK virus nephropathy. Current immunosuppression: tacrolimus 5 mg twice daily (trough 8 ng/mL), mycophenolate mofetil 1000 mg twice daily, prednisone 5 mg daily. What is the first immunosuppression modification?", "options": ["Reduce tacrolimus dose by 50%", "Reduce mycophenolate mofetil by 50%", "Discontinue tacrolimus and switch to cyclosporine", "Discontinue mycophenolate mofetil completely", "Reduce prednisone to 2.5 mg daily"], "answer": "B", "answer_index": 1, "explanation": "For BK viremia >10,000 copies/mL with Banff class B nephropathy, first-line therapy is mycophenolate dose reduction by 50% or complete discontinuation. Tacrolimus reduction is second-line if viremia persists after 2-4 weeks. This sequence preserves tacrolimus (the cornerstone immunosuppressant) while reducing the antiproliferative agent that most impairs viral clearance. Steroids should not be reduced initially.", "generator_model": "kimi-k2-thinking", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "abms_specialty": "Urology", "abms_source": "target_topic", "source_label_raw": "Urology", "source_quiz_id": "20251225T234023630Z_kimi-k2-thinking_seed133", "source_question_id": "20251225T234023630Z_kimi-k2-thinking_seed133-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251225T234023630Z_kimi-k2-thinking_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T234023630Z_kimi-k2-thinking_seed133.jsonl", "pred": "B", "model_outputs": "Let me analyze this case of BK virus nephropathy in a kidney transplant recipient.\n\nKey findings:\n- 8 months post-transplant\n- Rising creatinine (1.2 â†’ 2.1 mg/dL)\n- BK viremia: 18,000 copies/mL\n- Biopsy-confirmed BK nephropathy (Banff class B)\n- Current immunosuppression: tacrolimus, mycophenolate mofetil (MMF), prednisone\n\nBK virus nephropathy is caused by over-immunosuppression, and the primary treatment is reduction of immunosuppression to allow the immune system to control the virus.\n\nThe standard approach to immunosuppression reduction for BK nephropathy typically follows a stepwise approach:\n\n1. First step: Reduce or discontinue the antimetabolite (mycophenolate mofetil)\n2. Second step: If viremia persists, reduce the calcineurin inhibitor (tacrolimus)\n\nThe rationale for reducing MMF first:\n- MMF has a more profound effect on T-cell proliferation and viral immunity\n- Reducing MMF first is generally considered safer in terms of rejection risk compared to significantly reducing tacrolimus\n- Most guidelines recommend starting with antimetabolite reduction\n\nLooking at the options:\n- Option B (Reduce MMF by 50%) - This is the typical first step\n- Option D (Discontinue MMF completely) - This is more aggressive and usually done if initial reduction doesn't work\n- Option A (Reduce tacrolimus by 50%) - Usually second-line after MMF reduction\n\nThe standard first-line approach is to reduce MMF by 50% (or sometimes discontinue it), while maintaining adequate CNI levels initially. Given that this is asking for the \"first\" modification, reducing MMF by 50% is the most appropriate initial step before considering complete discontinuation.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-003", "question": "A 55-year-old man has left vocal fold paralysis 6 months after thyroidectomy, with persistent aspiration and breathy voice. EMG shows absent motor unit potentials. What is the optimal injection laryngoplasty material?", "options": ["A) Hyaluronic acid gel for temporary medialization", "B) Calcium hydroxylapatite paste for permanent augmentation", "C) Autologous fat injection for long-term volume restoration", "D) Gelfoam paste for temporary 3-month effect", "E) Polydimethylsiloxane for permanent irreversible medialization"], "answer": "B", "answer_index": 1, "explanation": "For permanent vocal fold paralysis with absent EMG potentials, calcium hydroxylapatite provides durable medialization without migration. Its high viscosity prevents particle dispersion, and it integrates into tissue without foreign body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat has unpredictable resorption (50-80% at 1 year), and polydimethylsiloxane risks granuloma formation and airway compromise if overinjected.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "abms_specialty": "Otolaryngology", "abms_source": "target_topic", "source_label_raw": "Otolaryngology", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nClinical Scenario:\n- 55-year-old man with left vocal fold paralysis\n- 6 months post-thyroidectomy\n- Persistent aspiration and breathy voice\n- EMG shows absent motor unit potentials\n\nKey Considerations:\n\n1. Timing: At 6 months post-injury, this is beyond the typical window for spontaneous recovery (usually 6-12 months is considered, but EMG findings are crucial here).\n\n2. EMG findings: Absent motor unit potentials indicate complete denervation with no evidence of reinnervation. This suggests the paralysis is likely permanent and recovery is unlikely.\n\n3. Material selection for injection laryngoplasty:\n\n- A) Hyaluronic acid: Temporary (3-6 months), good for diagnostic/therapeutic trial\n- B) Calcium hydroxylapatite (CaHA/Radiesse Voice): Semi-permanent to permanent (1-2+ years), good for long-term augmentation\n- C) Autologous fat: Long-term but variable resorption (30-50%), requires harvesting procedure\n- D) Gelfoam: Very temporary (4-6 weeks to 3 months), used when recovery is expected\n- E) Polydimethylsiloxane (silicone): Permanent but has fallen out of favor due to granuloma formation and migration risks\n\nDecision Analysis:\n\nGiven that:\n- EMG shows no motor unit potentials (permanent paralysis likely)\n- 6 months have passed (beyond early recovery window)\n- Patient has functional problems (aspiration, breathy voice)\n\nA permanent or long-lasting solution is appropriate. \n\n- Gelfoam (D) is too temporary for a permanent condition\n- Hyaluronic acid (A) is temporary - not optimal for permanent paralysis\n- Silicone (E) is permanent but has significant complications\n- Autologous fat (C) provides long-term results but has variable resorption\n- Calcium hydroxylapatite (B) provides durable, long-lasting augmentation and is commonly used for permanent vocal fold paralysis\n\nBest Answer: Calcium hydroxylapatite (CaHA) is the optimal choice for permanent vocal fold paralysis confirmed by EMG, as it provides durable medialization without the complications of silicone.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-004", "question": "A 45-year-old man with T6 complete spinal cord injury has a stage 4 sacral pressure ulcer with positive probe-to-bone test and MRI showing marrow edema limited to cortex. He has been on antibiotics for 4 weeks with minimal improvement. What is definitive management?", "options": ["A) Continue suppressive antibiotics indefinitely with wound care", "B) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap", "C) Radical debridement with partial sacrectomy and omental flap", "D) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks", "E) Osteomyelitis excision with free latissimus dorsi muscle flap"], "answer": "B", "answer_index": 1, "explanation": "Stage 4 sacral ulcer with cortical osteomyelitis requires surgical debridement with burr drilling of exposed bone to bleeding cortex, followed by VAC therapy to prepare granulation tissue, then gluteal myocutaneous flap coverage. This achieves 85% healing rates. Partial sacrectomy is reserved for medullary involvement. Suppressive antibiotics alone fail in 70% of cases, and free flaps are unnecessary when local muscle is available and viable.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "abms_specialty": "Physical Medicine and Rehabilitation", "abms_source": "target_topic", "source_label_raw": "Physical Medicine and Rehabilitation", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-017", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nKey findings:\n- T6 complete spinal cord injury (paraplegic patient)\n- Stage 4 sacral pressure ulcer (full thickness with exposed bone/muscle)\n- Positive probe-to-bone test (highly suggestive of osteomyelitis)\n- MRI showing marrow edema limited to cortex (superficial bone involvement)\n- Failed 4 weeks of antibiotics\n\nAnalysis of options:\n\nA) Continue suppressive antibiotics indefinitely with wound care\n- Not definitive management; antibiotics alone have failed and won't address the underlying wound/bone issue\n\nB) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap\n- This is the standard approach for sacral pressure ulcers with osteomyelitis\n- Burr drilling removes infected cortical bone while preserving deeper healthy bone\n- VAC therapy prepares the wound bed\n- Gluteal myocutaneous flap provides well-vascularized tissue coverage for the sacrum\n- Appropriate for cortical involvement (not deep marrow involvement)\n\nC) Radical debridement with partial sacrectomy and omental flap\n- Too aggressive for cortical-only involvement\n- Omental flap is rarely used for sacral wounds; more complex procedure\n- Reserved for more extensive disease\n\nD) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks\n- Antibiotics alone have already failed\n- Doesn't address the pressure ulcer or provide definitive surgical management\n\nE) Osteomyelitis excision with free latissimus dorsi muscle flap\n- Free flaps are generally not first-line for sacral pressure ulcers\n- Local/regional flaps (gluteal) are preferred when available\n- More complex with higher failure rates\n\nBest answer: The standard definitive management for sacral pressure ulcers with superficial osteomyelitis involves surgical debridement (including burr drilling of infected bone), wound bed preparation with VAC therapy, followed by coverage with a gluteal myocutaneous flap (which provides bulk, blood supply, and durable coverage).\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-005", "question": "A 71-year-old man with history of scalp radiation for basal cell carcinoma 20 years ago develops a 5 cm recurrent tumor with 2 cm calvarial erosion. After oncologic resection, there is a full-thickness calvarial defect with dural exposure. What is the optimal reconstruction?", "options": ["A) Latissimus dorsi myocutaneous free flap with split-thickness skin graft", "B) Omental free flap with vascularized bone graft", "C) Pericranial flap rotation with split calvarial graft", "D) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty", "E) Anterolateral thigh fasciocutaneous flap with titanium mesh"], "answer": "D", "answer_index": 3, "explanation": "In irradiated scalp defects with calvarial exposure, muscle-only free flaps (latissimus dorsi) provide robust vascularity to compromised beds while allowing secondary skin grafting. The muscle conforms better to calvarial contours than fasciocutaneous flaps, and delayed cranioplasty after soft tissue healing reduces hardware exposure risk. Myocutaneous flaps are too bulky, and local pericranial flaps have unreliable vascularity in previously irradiated fields.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "abms_specialty": "Plastic Surgery", "abms_source": "target_topic", "source_label_raw": "Plastic Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "D", "model_outputs": "Let me analyze this case systematically.\n\nKey factors to consider:\n1. Prior scalp radiation 20 years ago - this means local tissues are compromised (radiation damage, poor vascularity)\n2. Large defect (5 cm tumor with 2 cm calvarial erosion)\n3. Full-thickness calvarial defect with dural exposure\n4. Need for both soft tissue coverage AND calvarial reconstruction\n\nAnalyzing each option:\n\nA) Latissimus dorsi myocutaneous free flap with split-thickness skin graft\n- Provides good bulk and coverage\n- But skin graft on scalp is suboptimal aesthetically and functionally\n\nB) Omental free flap with vascularized bone graft\n- Omentum is rarely first choice for scalp\n- Complex procedure with abdominal morbidity\n\nC) Pericranial flap rotation with split calvarial graft\n- This uses LOCAL tissue\n- In a previously irradiated field, local flaps are unreliable due to radiation damage\n- The pericranium would be compromised from prior radiation\n- NOT a good choice in irradiated tissue\n\nD) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty\n- Brings well-vascularized tissue from outside the radiation field\n- Muscle flap provides excellent coverage for dura\n- Delayed cranioplasty is reasonable - allows wound healing first\n- Skin graft over muscle is acceptable\n\nE) Anterolateral thigh fasciocutaneous flap with titanium mesh\n- ALT is a good option for scalp reconstruction\n- Provides skin coverage\n- Titanium mesh for calvarial reconstruction\n- However, placing hardware in a previously irradiated field with potential for wound complications is concerning\n- Fasciocutaneous flap may not provide as much bulk/vascularity as muscle\n\nBest answer reasoning:\nGiven the irradiated field, we need tissue from OUTSIDE the radiation zone (eliminating C). The latissimus dorsi muscle flap brings robust, well-vascularized tissue that can help with wound healing in compromised tissue. Delaying cranioplasty until the wound is stable and healed reduces risk of hardware complications. This staged approach is safer in irradiated tissue.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-006", "question": "A 28-year-old woman presents with progressive myelopathy over 6 months. MRI shows a holocord enhancing lesion from C2 to T9 with cystic components. Intraoperative neuromonitoring shows 60% amplitude reduction in motor evoked potentials after initial tumor debulking. What is the next surgical decision?", "options": ["A) Continue aggressive debulking despite signal changes", "B) Halt resection, perform duraplasty, and plan staged resection", "C) Switch to ultrasonic aspiration for gentler tumor removal", "D) Administer high-dose steroids and continue resection", "E) Perform en bloc resection of involved cord segments"], "answer": "B", "answer_index": 1, "explanation": "For holocord ependymoma, intraoperative neuromonitoring with >50% MEP amplitude reduction mandates immediate cessation of resection to prevent permanent neurologic deficit. Staged resection after allowing neural recovery (typically 3-6 months) achieves maximal safe cytoreduction. Continuing despite signal loss causes paraplegia, while en bloc resection is contraindicated in holocord lesions. Ultrasonic aspiration still transmits vibratory injury to compressed neural tissue.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "abms_specialty": "Neurological Surgery", "abms_source": "target_topic", "source_label_raw": "Neurological Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "B", "model_outputs": "In this case, we have a patient with a holocord enhancing lesion (likely an intramedullary spinal cord tumor such as an ependymoma or astrocytoma) spanning from C2 to T9. During surgery, intraoperative neuromonitoring (IONM) shows a 60% amplitude reduction in motor evoked potentials (MEPs) after initial tumor debulking.\n\nThis is a critical finding. A significant reduction in MEP amplitude (typically >50%) is considered a warning sign of impending neurological injury. The standard practice in spinal cord tumor surgery is to use IONM to guide the extent of resection and protect neurological function.\n\nLet me analyze each option:\n\nA) Continue aggressive debulking despite signal changes - This would risk permanent neurological deficit and is not appropriate when IONM shows significant changes.\n\nB) Halt resection, perform duraplasty, and plan staged resection - This is the safest approach when significant IONM changes occur. Stopping the surgery preserves current function, duraplasty allows for cord swelling, and staged resection allows for recovery before attempting further removal.\n\nC) Switch to ultrasonic aspiration for gentler tumor removal - While ultrasonic aspiration is gentler, the MEP changes indicate the cord is already stressed. Simply changing technique doesn't address the underlying issue of cord compromise.\n\nD) Administer high-dose steroids and continue resection - Steroids may help with edema but continuing resection with significant MEP changes risks permanent deficit.\n\nE) Perform en bloc resection of involved cord segments - This would be catastrophic, causing complete paralysis, and is never appropriate for intramedullary tumors.\n\nThe 60% amplitude reduction is a significant warning that continuing surgery risks permanent motor deficits. The prudent approach is to stop, allow the cord to recover, and plan for staged resection if needed.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-007", "question": "A 62-year-old man with T2N0M0 glottic carcinoma involving the anterior commissure is scheduled for definitive radiation therapy. He has good performance status and no comorbidities. What is the optimal fractionation scheme to maximize local control?", "options": ["A) 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin", "B) 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab", "C) 72 Gy in 42 fractions using concomitant boost over 6 weeks", "D) 60 Gy in 30 fractions over 6 weeks with hyperfractionation", "E) 50 Gy in 20 fractions over 4 weeks with hypofractionation"], "answer": "C", "answer_index": 2, "explanation": "For T2 glottic cancer with anterior commissure involvement, altered fractionation with concomitant boost (72 Gy/42 fractions/6 weeks) improves 5-year local control to 85% versus 70% with standard fractionation, without increasing late toxicity. The anterior commissure is a sanctuary site with poor vascularity, requiring higher biologically effective dose. Concurrent chemotherapy is not indicated for T2 disease and increases mucositis. Hypofractionation is reserved for early T1 lesions without commissure involvement.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "abms_specialty": "Radiation Oncology", "abms_source": "target_topic", "source_label_raw": "Radiation Oncology", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-020", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "C", "model_outputs": "I need to determine the optimal fractionation scheme for a T2N0M0 glottic carcinoma involving the anterior commissure.\n\nKey considerations:\n1. This is an early-stage (T2N0) glottic laryngeal cancer\n2. Anterior commissure involvement is associated with higher local failure rates\n3. The goal is definitive radiation therapy to maximize local control\n4. Patient has good performance status\n\nLet me analyze each option:\n\nOption A: 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin\n- Standard fractionation with chemotherapy\n- For T2N0 glottic cancer, concurrent chemotherapy is not typically indicated as it doesn't improve outcomes but adds toxicity\n\nOption B: 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab\n- Adding cetuximab to early glottic cancer is not standard practice\n- Dose is also slightly lower\n\nOption C: 72 Gy in 42 fractions using concomitant boost over 6 weeks\n- This is an accelerated fractionation scheme (concomitant boost)\n- Delivers higher total dose in shorter overall treatment time\n- Addresses tumor repopulation which is important in head and neck cancers\n- Studies (like RTOG 90-03) showed improved local control with accelerated fractionation for head and neck cancers\n\nOption D: 60 Gy in 30 fractions over 6 weeks with hyperfractionation\n- 60 Gy is too low for definitive treatment\n- True hyperfractionation uses smaller doses twice daily with higher total dose\n\nOption E: 50 Gy in 20 fractions over 4 weeks with hypofractionation\n- 50 Gy is inadequate for definitive treatment of T2 glottic cancer\n\nFor T2 glottic carcinoma, especially with anterior commissure involvement (which has higher failure rates), accelerated fractionation has been shown to improve local control. The concomitant boost technique delivers 72 Gy in 6 weeks, which addresses the issue of accelerated tumor repopulation and provides adequate dose intensity.\n\nFor early glottic cancer (T1-T2 N0), chemotherapy is not routinely added as it increases toxicity without clear benefit. Altered fractionation (accelerated or hyperfractionated) has shown improved local control in randomized trials.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-008", "question": "A 68-year-old man is 18 days post-Ivor Lewis esophagectomy with gastric conduit reconstruction for stage III esophageal adenocarcinoma. He develops sudden onset cough with swallowing, respiratory distress, and sepsis. Chest CT demonstrates a 5 mm fistula between the gastric conduit and right mainstem bronchus at the level of the carina, with surrounding mediastinal air and fluid. Bronchoscopy confirms the fistula with conduit mucosa visible. What is the definitive management?", "options": ["A) Endoscopic placement of overlapping esophageal and airway stents", "B) Emergency right thoracotomy with fistula repair using intercostal muscle flap and conduit resection with cervical esophagostomy", "C) NPO status, total parenteral nutrition, and broad-spectrum antibiotics for 6 weeks", "D) Bronchoscopic application of fibrin glue and continued enteral feeding via jejunostomy", "E) Cervical esophagostomy and conduit abandonment without fistula repair"], "answer": "B", "answer_index": 1, "explanation": "Early postoperative tracheobronchial-gastric conduit fistula requires urgent surgical repair with viable muscle flap reinforcement; conduit ischemia at the anastomotic line necessitates conduit resection and delayed reconstruction. Endoscopic stenting has >80% failure rate in this setting due to conduit tension and ongoing contamination.", "generator_model": "kimi-k2-thinking", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "abms_specialty": "Thoracic Surgery", "abms_source": "target_topic", "source_label_raw": "Thoracic Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed131", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed131-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed131.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nClinical Scenario:\n- 68-year-old man, 18 days post-Ivor Lewis esophagectomy\n- Sudden cough with swallowing, respiratory distress, sepsis\n- CT shows 5mm fistula between gastric conduit and right mainstem bronchus\n- Mediastinal air and fluid (mediastinitis)\n- Bronchoscopy confirms fistula\n\nThis is a gastrobronchial fistula - a devastating complication after esophagectomy with gastric pull-up.\n\nKey considerations:\n1. Patient is septic with mediastinitis - this is life-threatening\n2. The fistula is at the carina level (central airway)\n3. 18 days post-op - tissues are in the inflammatory phase, not ideal for primary repair\n4. 5mm fistula is relatively small but causing significant contamination\n\nAnalyzing options:\n\nA) Endoscopic stenting (esophageal + airway): This is increasingly used as a bridge or definitive therapy for anastomotic leaks and fistulas. Dual stenting can seal the fistula, control sepsis, and allow healing. However, for a gastrobronchial fistula with active sepsis, this may not provide adequate source control.\n\nB) Emergency thoracotomy with fistula repair, intercostal muscle flap, conduit resection, cervical esophagostomy: This is the most aggressive surgical approach - addresses the fistula directly, provides vascularized tissue coverage, removes the contaminated conduit, and creates diversion. This is definitive management for a septic patient with mediastinitis.\n\nC) Conservative management (NPO, TPN, antibiotics): Unlikely to work for an established fistula with sepsis and mediastinitis. This is not definitive.\n\nD) Fibrin glue: Too conservative for a 5mm fistula with sepsis.\n\nE) Cervical esophagostomy and conduit abandonment WITHOUT fistula repair: This doesn't address the ongoing contamination from the fistula itself.\n\nDecision:\nGiven the sepsis, mediastinitis, and established fistula, the patient needs definitive surgical intervention. Option B provides complete source control: fistula repair with vascularized tissue (intercostal muscle flap), removal of the contaminated conduit, and diversion via cervical esophagostomy. This is the standard of care for this catastrophic complication in a septic patient.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-009", "question": "A 72-year-old man has a 5.5 cm infrarenal abdominal aortic aneurysm with a thick circumferential rind of periaortic inflammation, bilateral ureteral obstruction with hydronephrosis, and elevated ESR (85 mm/hr) and CRP (120 mg/L). What is the optimal management sequence?", "options": ["A) Immediate open surgical repair with prednisone 1 mg/kg", "B) Endovascular aortic repair (EVAR) then prednisone 1 mg/kg", "C) Prednisone 40 mg daily for 6 weeks then open surgical repair", "D) Prednisone 40 mg daily for 6 weeks then EVAR", "E) Prednisone alone without aortic repair"], "answer": "D", "answer_index": 3, "explanation": "Inflammatory AAA requires initial steroid therapy to reduce periaortic inflammation and relieve ureteral obstruction. Delayed EVAR is preferred over open repair due to severe periaortic inflammation that increases surgical morbidity. Steroids alone risk aneurysm rupture.", "generator_model": "kimi-k2-thinking", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "abms_specialty": "Vascular Surgery", "abms_source": "target_topic", "source_label_raw": "Vascular Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed131", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed131-012", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed131.jsonl", "pred": "D", "model_outputs": "This case describes an inflammatory abdominal aortic aneurysm (IAAA), characterized by:\n- Periaortic inflammation (thick circumferential rind)\n- Bilateral ureteral obstruction with hydronephrosis\n- Elevated inflammatory markers (ESR 85, CRP 120)\n- 5.5 cm infrarenal AAA\n\nKey considerations:\n\n1. Size indication for repair: At 5.5 cm, this aneurysm meets the threshold for elective repair.\n\n2. Inflammatory AAA management: This is a special variant where the inflammatory process causes retroperitoneal fibrosis leading to ureteral entrapment.\n\n3. Treatment approach:\n   - Steroids (prednisone) are effective in reducing periaortic inflammation and can help resolve ureteral obstruction\n   - Pre-operative steroid therapy can reduce inflammation, making surgery safer and potentially allowing ureteral obstruction to resolve\n   - EVAR is generally preferred over open repair for inflammatory AAA because:\n     - Less surgical trauma\n     - Avoids the hostile inflammatory tissue\n     - Lower perioperative morbidity\n     - The inflammatory process often regresses after excluding the aneurysm from circulation\n\n4. Sequence: Starting with steroids for several weeks allows:\n   - Reduction of inflammation\n   - Potential improvement in ureteral obstruction\n   - Better surgical conditions if needed\n   - Then EVAR can be performed more safely\n\n5. Why not immediate surgery: The dense inflammatory tissue makes immediate open repair technically challenging with higher complication rates.\n\n6. Why not steroids alone: The aneurysm is 5.5 cm and requires repair to prevent rupture.\n\nThe optimal sequence is medical therapy with steroids first to reduce inflammation, followed by EVAR (preferred over open repair for inflammatory AAA).\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-010", "question": "An 18-year-old male with genetically confirmed Danon disease (LAMP2 mutation) presents with severe hypertrophic cardiomyopathy (septal thickness 28 mm), ventricular pre-excitation (WPW pattern on ECG), and recurrent syncope. Electrophysiology study identifies three distinct accessory pathways. Despite maximal medical therapy, he continues to have pre-excited atrial fibrillation. What is the most appropriate next management step?", "options": ["A) Initiate flecainide therapy", "B) Perform catheter ablation of all accessory pathways", "C) Increase beta-blocker dosage", "D) Evaluate for heart transplantation", "E) Implant a dual-chamber pacemaker"], "answer": "D", "answer_index": 3, "explanation": "Danon disease causes rapidly progressive HCM, multiple accessory pathways, and skeletal myopathy with poor prognosis. Catheter ablation is often unsuccessful due to rapid pathway recurrence and progressive myocardial involvement. Beta-blockers and verapamil are contraindicated in WPW with pre-excited AF. Flecainide may transiently suppress pathways but doesn't alter disease course. Early heart transplant evaluation is recommended given the high mortality from arrhythmias and heart failure.", "generator_model": "kimi-k2-thinking", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed124", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed124-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed124.jsonl", "pred": "D", "model_outputs": "Let me analyze this case systematically.\n\nThis 18-year-old male has Danon disease (LAMP2 mutation) with:\n- Severe hypertrophic cardiomyopathy (septal thickness 28 mm)\n- WPW pattern (ventricular pre-excitation)\n- Multiple accessory pathways (3 identified)\n- Recurrent syncope\n- Pre-excited atrial fibrillation despite maximal medical therapy\n\nKey considerations:\n\nDanon disease is an X-linked lysosomal storage disorder causing severe HCM, typically with rapid progression in males. It's associated with multiple accessory pathways (often posteroseptal) and has a poor prognosis - males often require heart transplantation by their 20s.\n\nPre-excited atrial fibrillation is dangerous because rapid conduction through accessory pathways can lead to ventricular fibrillation and sudden death.\n\nLet me evaluate each option:\n\nA) Flecainide - Contraindicated in structural heart disease (severe HCM). Also, in pre-excited AF, AV nodal blocking agents should be avoided, and while flecainide can slow accessory pathway conduction, it's not appropriate here given the structural heart disease.\n\nB) Catheter ablation - While typically first-line for WPW with symptomatic arrhythmias, in Danon disease, multiple accessory pathways are common and often recur after ablation. The success rate is lower, and new pathways can develop. Additionally, with severe HCM and ongoing symptoms, this may not address the underlying progressive cardiomyopathy.\n\nC) Increase beta-blocker - Already on maximal medical therapy, and beta-blockers alone won't prevent rapid conduction through accessory pathways in AF.\n\nD) Heart transplantation evaluation - Given Danon disease in a male with severe HCM (28mm septum), recurrent syncope (suggesting high arrhythmic risk), multiple accessory pathways, and refractory symptoms despite maximal therapy, transplant evaluation is appropriate. Danon disease in males has rapid progression, and transplantation is often the definitive treatment.\n\nE) Dual-chamber pacemaker - Does not address the arrhythmia risk or underlying disease.\n\nGiven the severity of disease, the progressive nature of Danon cardiomyopathy in males, multiple accessory pathways (which are difficult to ablate and tend to recur in Danon disease), and refractory symptoms, heart transplantation evaluation is the most appropriate next step.\n\nThe answer is (D)"}]